SUBSCRIBE
SUBSCRIBE
News   Business

Samsung Group, Quintiles Transnational Corp. Plan $266 Million Venture to Make Biologic Drugs

February 25, 2011 | 
1 min read
Bloomberg -- Samsung Group, the South Korean company whose businesses range from electronics to ship-building, will partner with Quintiles Transnational Corp. to make biologic drugs as it seeks new businesses to drive growth.
Alliances
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
AC Immune To Cut 30% of Workforce
September 5, 2025
 · 
196 min read
 · 
BioSpace Editorial Staff
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac